A Okša

1.1k total citations
21 papers, 351 citations indexed

About

A Okša is a scholar working on Nephrology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, A Okša has authored 21 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Pathology and Forensic Medicine and 4 papers in Physiology. Recurrent topics in A Okša's work include Vitamin D Research Studies (4 papers), Adenosine and Purinergic Signaling (4 papers) and Pharmacology and Obesity Treatment (3 papers). A Okša is often cited by papers focused on Vitamin D Research Studies (4 papers), Adenosine and Purinergic Signaling (4 papers) and Pharmacology and Obesity Treatment (3 papers). A Okša collaborates with scholars based in Slovakia, Czechia and Austria. A Okša's co-authors include Viera Spustová, J Škrha, R Dzúrik, Domenico Fedele, W Grzeszczak, Stanisław Czekałski, Giovanni Gambaro, I Kinalska, J Tatoń and Jacek Manitius and has published in prestigious journals such as Journal of the American Society of Nephrology, Molecules and BioMed Research International.

In The Last Decade

A Okša

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Okša Slovakia 8 187 89 74 68 51 21 351
L Hanna United States 8 267 1.4× 222 2.5× 55 0.7× 187 2.8× 73 1.4× 11 616
Abdussalam Elshakmak Germany 5 211 1.1× 53 0.6× 42 0.6× 80 1.2× 50 1.0× 6 342
D. Travia Italy 10 147 0.8× 161 1.8× 80 1.1× 98 1.4× 86 1.7× 17 451
Naoko Deji Japan 6 86 0.5× 97 1.1× 25 0.3× 44 0.6× 66 1.3× 14 343
Carolina Hernández-Carballo Spain 9 185 1.0× 95 1.1× 35 0.5× 36 0.5× 97 1.9× 17 415
Laura Buzzi Italy 11 123 0.7× 156 1.8× 24 0.3× 154 2.3× 96 1.9× 18 390
Maria G. Dekker Canada 9 239 1.3× 201 2.3× 21 0.3× 134 2.0× 70 1.4× 9 474
Lasse Bent-Hansen Denmark 10 120 0.6× 150 1.7× 16 0.2× 112 1.6× 62 1.2× 15 381
G. C. Viberti United Kingdom 10 177 0.9× 182 2.0× 16 0.2× 212 3.1× 51 1.0× 16 607
Adela Brahimaj Netherlands 9 79 0.4× 144 1.6× 47 0.6× 54 0.8× 116 2.3× 9 404

Countries citing papers authored by A Okša

Since Specialization
Citations

This map shows the geographic impact of A Okša's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Okša with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Okša more than expected).

Fields of papers citing papers by A Okša

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Okša. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Okša. The network helps show where A Okša may publish in the future.

Co-authorship network of co-authors of A Okša

This figure shows the co-authorship network connecting the top 25 collaborators of A Okša. A scholar is included among the top collaborators of A Okša based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Okša. A Okša is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Covic, Adrian, Marcus D. Säemann, Ryszard Gellert, et al.. (2024). The importance of early diagnosis and intervention in chronic kidney disease: Calls-to-action from nephrologists based mainly in Central/Eastern Europe. Kidney & Blood Pressure Research. 49(1). 218–227. 2 indexed citations
4.
Okša, A, et al.. (2018). Purinergic P2X7 Receptors and Chronic Kidney Disease. 4(2). 1 indexed citations
5.
Okša, A, et al.. (2017). Expression of purinergic P2X7 receptors in subpopulations of peripheral blood mononuclear cells in early-stage of chronic kidney disease.. PubMed. 68(5). 779–785. 4 indexed citations
6.
Spustová, Viera, et al.. (2016). MP015THE EFFECT OF VITAMIN D3 SUPPLEMENTATION ON P2X7 RECEPTOR FUNCTION IN EARLY STAGES OF CHRONIC KIDNEY DISEASE. Nephrology Dialysis Transplantation. 31(suppl_1). i347–i348. 1 indexed citations
7.
Okša, A, et al.. (2016). [Vitamin D3 supplementation and cellular calcium homeostasis in patients with chronic kidney disease].. PubMed. 62 Suppl 6. 40–45. 1 indexed citations
8.
Spustová, Viera, A Okša, D. Chorvát, et al.. (2015). The Impact of Vitamin D3Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease. BioMed Research International. 2015. 1–12. 5 indexed citations
9.
Okša, A, et al.. (2012). [Chronic kidney disease and cellular calcium homeostasis].. PubMed. 58(7-8). 525–30. 1 indexed citations
11.
Spustová, Viera, et al.. (2011). Insulin Resistance and Vitamin D Deficiency in Patients With Chronic Kidney Disease Stage 2-3. Physiological Research. 60(1). 149–155. 22 indexed citations
12.
Spustová, Viera, et al.. (2009). Intracellular calcium homeostasis in patients with early stagesof chronic kidney disease: effects of vitamin D3 supplementation. Nephrology Dialysis Transplantation. 24(11). 3376–3381. 22 indexed citations
13.
Okša, A, Viera Spustová, Zora Krivošíková, et al.. (2008). Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease. Kidney & Blood Pressure Research. 31(5). 322–329. 46 indexed citations
14.
Demes, Melanie, et al.. (2006). [Collagenofibrotic glomerulopathy--rare glomerulonephritis].. PubMed. 52(12). 1200–4. 3 indexed citations
15.
Okša, A. (2006). Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers?. PubMed. 107(8). 314–9. 2 indexed citations
16.
Gambaro, Giovanni, I Kinalska, A Okša, et al.. (2002). Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients. Journal of the American Society of Nephrology. 13(6). 1615–1625. 150 indexed citations
17.
Okša, A, et al.. (1999). [The effect of glycosaminoglycan sulodexide on albuminuria in patients with diabetes mellitus].. PubMed. 100(9). 486–9. 8 indexed citations
18.
Okša, A, et al.. (1998). [Celiprolol improves glucose metabolism in essential hypertension].. PubMed. 44(2). 63–7. 1 indexed citations
19.
Škrha, J, et al.. (1997). Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients. Diabetes Research and Clinical Practice. 38(1). 25–31. 38 indexed citations
20.
Okša, A, et al.. (1994). Effects of Angiotensin-Converting Enzyme Inhibitors on Glucose and Lipid Metabolism in Essential Hypertension. Journal of Cardiovascular Pharmacology. 23(1). 79–86. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026